3.IgG4-related sclerosing disease mimicking Castleman's disease: report of a case.
Quanhong QIN ; Mingfang ZHANG ; Zhiqi YIN ; Zhandong HU
Chinese Journal of Pathology 2014;43(3):194-195
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Castleman Disease
;
immunology
;
pathology
;
Cyclophosphamide
;
therapeutic use
;
Diagnostic Errors
;
Doxorubicin
;
therapeutic use
;
Humans
;
Immunoglobulin G
;
blood
;
Kidney
;
Lymph Node Excision
;
Lymph Nodes
;
pathology
;
surgery
;
Lymphatic Diseases
;
drug therapy
;
immunology
;
pathology
;
surgery
;
Male
;
Middle Aged
;
Nephrectomy
;
Pancreas
;
Plasma Cells
;
immunology
;
pathology
;
Prednisone
;
therapeutic use
;
Submandibular Gland
;
Vincristine
;
therapeutic use
5.Experimental Study of Vascular Tissue Engineering
Tai YIN ; Yingxin XU ; Shihe WU ; Jinjing WANG ; Lingling E ; Rong LI ; Ruixin LI ; Xizheng ZHANG
Chinese Journal of Rehabilitation Theory and Practice 2007;13(6):526-527
Objective To obtain the experimental data of vascular tissue engineering.MethodsThe vascular endothelial cells (VEC) and vascular smooth muscle cells (VSMCs) were acquired and cultured, and then seeded on vascular tissue engineering materials. The porous gelatin-chitosan scaffold with VSMCs was subcutaneously implanted, followed by the observation of the cell growth ten days later.ResultsThe two kinds of cells were successfully cultured and their morpholoical and immunohistochemical characteristics were consistent with vascular endothelial and VSMCs respectively. The VSMCs could grow extensively on the scaffold after the in vivo implantation. The scaffold were wrapped by the fibrous tissue ten days later after the in vitro implantation of VSMCs. The seed cells grew in the scaffold, and the vessel cavity seen in the center of the scaffold, was quite different from the normal vessel structure.ConclusionIt is feasible to implant the VSMCs with fibrin gels into the living body. The vessels reconstructed, though different from the normal structure, is similar to the embryo of the vessels.
6.Elementary study on construction of engineered blood vessel using chitosan-fibrin gel as scaffold
Yingxin XU ; Tai YIN ; Ruixin LI ; Shihe WU ; Jinjing WANG ; Lingling E ; Xizheng ZHANG ; Rong LI
Chinese Journal of Rehabilitation Theory and Practice 2005;11(8):623-625
ObjectiveTo investigate the feasibility of construction of engineered blood vessel using chitosan tube and fibrin gel as scaffold.MethodsVascular endothelial cells and smooth muscle cells were harvested from aortas of a rat, respectively. After expansion in vitro, vascular endothelial cells were seeded onto the inner surface of chitosan tube and smooth muscle cells mixed with fibrin gel seeded onto outer surface of the scaffold to construct engineered blood vessels. Inverted microscope, immunohistochemical staining and scanning electronic microscope were used to evaluate the construct.ResultsVascular endothelial cells formed monolayer and covered the inner surface of chitosan tube. Smooth muscle cells survived in the fibrin gel and grew in a 3-dimensional manner. ConclusionChitosan-fibrin gel may be potentially used as scaffold of engineered blood vessels.
8.Idiopathic arterial calcification of infancy:report of a case.
Feng-lan GAO ; Chun-ling LIU ; Yin-po ZHANG ; Yan-xin ZHANG
Chinese Journal of Pathology 2013;42(11):771-772
Autopsy
;
Female
;
Heart Failure
;
etiology
;
pathology
;
Humans
;
Infant
;
Myocardial Infarction
;
etiology
;
pathology
;
Vascular Calcification
;
complications
;
pathology
9.Activation of ERK1/2 in spinal cord contributes to the development of acute cystic pain in rabbits.
Yong-Hong WANG ; E-mail: LCZHANG@XZMC.EDU.CN. ; Li-Cai ZHANG ; Yin-Ming ZENG
Neuroscience Bulletin 2006;22(4):216-220
Objective To investigate the role of activated extracellular signal-regulated kinase 1/2 (ERK1/2) in spinal cord in the development of cystic pain in rabbit. Methods We observed the relationship between the activation of ERK1/2 in spinal cord and nociceptive behaviors, as well as the effect of U0126, a mitogen-activated protein kinase (MEK, upstream protein of ERK1/2) inhibitor, on cystic pain in rabbits by behavioral test, immunohistochemistry and western blot analysis. Results After injecting 0.5 ml formalin into gallbladder, the behaviors such as grasping of the cheek and licking of the abdomen increased in 30 min, with a significant increase in pERK1/2 expression in the spinal cord, as well as the pERK1/2 immunoreactive cells located in laminae V-VII and X of the dorsal horn and ventral horn of T6 spinal cord. Administration of U0126 (100 - 400 mu g/kg body weight, i.v., 10 min before instillation of formalin) could attenuated nociceptive behaviors dose-dependently, but could not restrain the nociceptive behaviors completely even at the maximal efficient dose of 400 mu g/kg body weight. Conclusion Activated ERK1/2 in the spinal cord at least partly participates in the development of acute inflammatory cystic pain induced by formalin in rabbits.
10.Primary cutaneous follicle centre lymphoma: report of a case.
Yin-fang RONG ; Lin-ming HE ; Yong-sheng ZHANG ; Yi-zhong FENG
Chinese Journal of Pathology 2013;42(11):769-770
Antigens, CD20
;
metabolism
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Burkitt Lymphoma
;
metabolism
;
pathology
;
CD79 Antigens
;
metabolism
;
Cyclophosphamide
;
therapeutic use
;
DNA-Binding Proteins
;
metabolism
;
Diagnosis, Differential
;
Doxorubicin
;
therapeutic use
;
Humans
;
Lymphoma, B-Cell
;
pathology
;
Lymphoma, Follicular
;
drug therapy
;
metabolism
;
pathology
;
Lymphoma, Large B-Cell, Diffuse
;
metabolism
;
pathology
;
Male
;
Middle Aged
;
Prednisone
;
therapeutic use
;
Proto-Oncogene Proteins c-bcl-6
;
Skin Neoplasms
;
drug therapy
;
metabolism
;
pathology
;
Vincristine
;
therapeutic use